EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Aldosterone in Vascular Permeability in Diabetes

Michal Aleksiejczuk iD, Natalia Bielicka iD, Magdalena Bruzgo-Grzybko iD, Izabela Suwda Kalita iD, Adam Jan Olichwier iD, Paulina Mierzejewska iD, Joanna Stelmaszewska, Janusz Dzieciol iD, Ewa Chabielska iD, Anna Gromotowicz-Poplawska iD

Cells · 2026

DOI: 10.3390/cells15010089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Michal Aleksiejczuk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy and Radiopharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: Capillary Permeability, Diabetes Mellitus, Experimental, Aldosterone. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 30% of diabetic patients develop dermatopathies linked to inflammation and increased vascular permeability. Considering the role of the renin–angiotensin–aldosterone system (RAAS) in diabetic complications, this study examined whether aldosterone (ALDO) and the mineralocorticoid receptor (MR) contribute to diabetes-related skin microangiopathy. Vascular permeability was measured in normoglycemic rats and insulin-dependent (streptozotocin-induced) diabetic rats. The expression of MR, 11β-hydroxysteroid dehydrogenase type 2 (HSD11β2), vascular endothelial growth factor (VEGF), von Willebrand factor (vWF), and the tight junction protein ZO-1 was determined by PCR and immunohistochemistry. Diabetic rats received the MR antagonist eplerenone (EPL, 100 mg/kg) for 10 days. Additionally, the effects of ALDO and EPL on endothelial permeability were evaluated in human dermal microvascular endothelial cells (HMEC-1) using a Transwell system. Diabetic rats showed skin atrophy, collagen damage, elevated ALDO levels, reduced MR and HSD11β2 expression, and increased vascular permeability, along with upregulation of VEGF and vWF. EPL markedly reduced these abnormalities. In vitro, ALDO increased endothelial permeability under hyperglycemia, and EPL counteracted this effect. These findings indicate that activation of the ALDO/MR pathway promotes skin vascular permeability in diabetes through VEGF- and vWF-dependent mechanisms. MR blockade limits these changes, suggesting therapeutic potential in preventing diabetes-associated skin complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capillary PermeabilityDiabetes Mellitus, ExperimentalAldosteroneAnimalsMaleVascular Endothelial Growth Factor AHumansRatsEplerenoneSkinvon Willebrand FactorReceptors, MineralocorticoidEndothelial Cells11-beta-Hydroxysteroid Dehydrogenase Type 2

Stichwörter der Autor:innen

VEGFaldosteronediabeteseplerenonemineralocorticoid receptorvWFvascular permeability

Substanzen

AldosteroneVascular Endothelial Growth Factor AEplerenonevon Willebrand FactorReceptors, Mineralocorticoid11-beta-Hydroxysteroid Dehydrogenase Type 2

Autor:innen und Institutionen

  • Department of Biopharmacy and Radiopharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland.
  • Radiopharmacy Centre, Medical University of Bialystok, 15-569 Bialystok, Poland.
  • Department of Biochemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.
  • Department of Pharmaceutical and Biopharmaceutical Analysis, Medical University of Bialystok, 15-222 Bialystok, Poland.
  • Department of Human Anatomy, Medical University of Bialystok, 15-222 Bialystok, Poland.

ORCID-Profile: Michal Aleksiejczuk, Natalia Bielicka, Magdalena Bruzgo-Grzybko, Izabela Suwda Kalita, Adam Jan Olichwier, Paulina Mierzejewska, Janusz Dzieciol, Ewa Chabielska, Anna Gromotowicz-Poplawska

Förderung

  • Medical University of Bialystok

Zitieren

APA

Aleksiejczuk, M., Bielicka, N., Bruzgo-Grzybko, M., Kalita, I. S., Olichwier, A. J., Mierzejewska, P., Stelmaszewska, J., Dzieciol, J., Chabielska, E., & Gromotowicz-Poplawska, A. (2026). The Role of Aldosterone in Vascular Permeability in Diabetes. Cells. https://doi.org/10.3390/cells15010089

Vancouver

Aleksiejczuk M, Bielicka N, Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Mierzejewska P, et al. The Role of Aldosterone in Vascular Permeability in Diabetes. Cells. 2026. doi:10.3390/cells15010089

BibTeX
@article{Aleksiejczuk2026,
  author = {Aleksiejczuk, Michal and Bielicka, Natalia and Bruzgo-Grzybko, Magdalena and Kalita, Izabela Suwda and Olichwier, Adam Jan and Mierzejewska, Paulina and Stelmaszewska, Joanna and Dzieciol, Janusz and Chabielska, Ewa and Gromotowicz-Poplawska, Anna},
  title = {The Role of Aldosterone in Vascular Permeability in Diabetes},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15010089}
}
Kostenlos starten →